4 Results

People

  1. Hassoun
    Hassoun
  2. Hultcrantz
    Hultcrantz
  3. Korde
    Korde
  4. Lahoud
    Lahoud
  5. Lesokhin
    Lesokhin
  6. Mailankody
    Mailankody
  7. Salcedo
    Salcedo
  8. Shah
    Shah
  9. Chung
    Chung
  10. Giralt
    Giralt

Groups

  1. CTCR Scholars (4)
  2. Center for Hematologic Malignancies (4)
  3. Department of Medicine (4)
  4. Hematologic Malignancies Research (4)
  5. Hematologic Malignancies, Division of (4)
  6. Myeloma (4)
  7. Sloan Kettering Institute Postdocs (4)
  8. Survivorship Research (4)
  9. Biostatistics Service (3)
  10. Bone Marrow Transplant (3)
  1. "clinical article"
  2. "Meghan Salcedo"
Formats
  1. Correspondence (2)
  2. Journal Article (1)
  3. Research Letter (1)
Groups
  1. CTCR Scholars (4)
  2. Center for Hematologic Malignancies (4)
  3. Department of Medicine (4)
  4. Hematologic Malignancies Research (4)
  5. Hematologic Malignancies, Division of (4)
  6. Myeloma (4)

More Groups

People
  1. Alexander Lesokhin (4)
  2. Hani Hassoun (4)
  3. Malin Hultcrantz (4)
  4. Meghan Salcedo (4)
  5. Neha Korde (4)
  6. Oscar Lahoud (4)

More People

Years
  1. 2022 (2)
  2. 2021 (1)
  3. 2020 (1)
Publications
  1. Leukemia and Lymphoma (2)
  2. Clinical Lymphoma, Myeloma and Leukemia (1)
  3. JAMA Oncology (1)
Publishers
  1. Taylor & Francis Group (2)
  2. American Medical Association (1)
  3. Elsevier Inc. (1)

Results (4)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A short course of daratumumab in patients with multiple myeloma and minimal residual disease after induction therapy
    Correspondence

    Nath, K.; Shekarkhand, T.; Salcedo, M.; Derkach, A.; Rueda, S.; Chansakul, A.; Hulcrantz, M.; Korde, N.; Shah, U. A.; Tan, C.; more...
    Leukemia and Lymphoma (2022)

    Fulltext@MSK | Save
  • Ixazomib and dexamethasone in high risk smoldering multiple myeloma: A clinical and correlative pilot study
    Correspondence

    Mailankody, S.; Salcedo, M.; Tavitian, E.; Burge, M.; Korde, N.; Hassoun, H.; Lesokhin, A.; Lahoud, O.; Smith, E.; Hultcrantz, M.; more...
    Leukemia and Lymphoma (2022)

    Fulltext@MSK | Save
  • Safety and effectiveness of weekly carfilzomib, lenalidomide, dexamethasone, and daratumumab combination therapy for patients with newly diagnosed multiple myeloma the MANHATTAN nonrandomized clinical trial
    Journal Article

    Landgren, O.; Hultcrantz, M.; Diamond, B.; Lesokhin, A. M.; Mailankody, S.; Hassoun, H.; Tan, C.; Shah, U. A.; Lu, S. X.; Salcedo, M.; more...
    JAMA Oncology (2021)

    Fulltext@MSK | Save
  • Phase I study of selinexor, ixazomib, and low-dose dexamethasone in patients with relapsed or refractory multiple myeloma
    Research Letter

    Salcedo, M.; Lendvai, N.; Mastey, D.; Schlossman, J.; Hultcrantz, M.; Korde, N.; Mailankody, S.; Lesokhin, A.; Hassoun, H.; Smith, E.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2020)

    Fulltext@MSK | Save